Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Inventory (2016 - 2025)

Jaguar Health (JAGX) has disclosed Change in Inventory for 11 consecutive years, with -$91000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 177.12% to -$91000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $954000.0, a 26.33% decrease, with the full-year FY2024 number at $1.2 million, down 46.61% from a year prior.
  • Change in Inventory was -$91000.0 for Q3 2025 at Jaguar Health, down from $165000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.9 million in Q2 2022 to a low of -$420000.0 in Q2 2023.
  • A 5-year average of $412947.4 and a median of $209000.0 in 2025 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 7645.45% in 2023, then crashed 177.12% in 2025.
  • Jaguar Health's Change in Inventory stood at $387000.0 in 2021, then grew by 9.3% to $423000.0 in 2022, then soared by 91.49% to $810000.0 in 2023, then dropped by 17.16% to $671000.0 in 2024, then tumbled by 113.56% to -$91000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Change in Inventory are -$91000.0 (Q3 2025), $165000.0 (Q2 2025), and $209000.0 (Q1 2025).